Support of existing NHSBT owned Extracorporial Photopheresis Systems

A Contract Award Notice
by NHS BLOOD AND TRANSPLANT

Source
Contracts Finder
Type
Contract (Products)
Duration
3 year
Value
£5M-£8M
Sector
HEALTH
Published
19 Dec 2024
Delivery
01 Feb 2025 to 31 Jan 2028
Deadline
19 Dec 2024 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The contract award is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend.

Award Detail

1 Therakos (Staines)
  • Value: £8,000,000

CPV Codes

  • 33140000 - Medical consumables
  • 50420000 - Repair and maintenance services of medical and surgical equipment

Indicators

  • Contract is suitable for SMEs.

Other Information

This contract has been awarded

Reference

Domains